Duncan Moore

Duncan Moore

Director/Board Member at ASP ISOTOPES INC.

Net worth: 8 M $ as of 31/05/2026

67 year
Health Technology
Consumer Services
Finance

Profile

Duncan Charles Mcnaught Moore is the founder of Ultraclone Ltd. Current positions include Chairman at Scottish Lifesciences Association and Allarity Therapeutics Europe ApS since 2015, Deputy Chairman at Braidlock Ltd., Independent Non-Executive Director at GH Research Plc starting 2025, Director at Cycle Pharmaceuticals Ltd. since 2014, Independent Non-Executive Director at ASP Isotopes, Inc. since 2021, Partner at East West Capital Partners Pte Ltd. since 2008, and Member of the Governors Board at both International School of Beijing and Merchiston Castle School.
Former roles include Chairman at Lamellar Biomedical Ltd., Oncology Venture Sweden AB, Allarity Therapeutics A, StepJockey Ltd., and Allarity Therapeutics, Inc. from 2021 to 2023, Independent Director at Forward Pharma A, and Research Analyst at Morgan Stanley & Co. International Plc from 1991 to 2008.
Education includes undergraduate studies at the University of Leeds and graduate and doctorate degrees from the University of Cambridge.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
29/04/2026 10,44,928 ( 0.83% ) 8 M $ 31/05/2026
18/03/2026 14,600 ( 0.02% ) 350 254 $ 31/05/2026

Duncan Moore active positions

CompaniesPositionStart
GH RESEARCH PLC Director/Board Member 24/09/2021
ASP ISOTOPES INC. Director/Board Member 01/10/2021
Director/Board Member 27/06/2014
Chairman -
Director/Board Member -
Corporate Officer/Principal -
Private Equity Investor 01/05/2008
Chairman 01/02/2015
Director/Board Member -

Former positions of Duncan Moore

CompaniesPositionEnd
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░ ░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ -
░░░░░░░░░░ ░░░░ ░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ -
See the detail of Duncan Moore's experience

Training of Duncan Moore

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

19

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies19

Consumer Services

Consumer Services

Finance

Commercial Services

Health Technology

Finance

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Ultraclone Ltd.

Health Technology

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!